ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

ClinicalTrials.gov ID: NCT00329030

Public ClinicalTrials.gov record NCT00329030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 12:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Rituxan/BEAM vs. Bexxar/BEAM With Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-cell Non-Hodgkin's Lymphoma (BMTCTN0401)

Study identification

NCT ID
NCT00329030
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Enrollment
224 participants

Conditions and interventions

Interventions

  • Autologous transplantation using Bexxar/BEAM Drug
  • Autologous transplantation using rituxan/BEAM Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2005
Primary completion
Jul 31, 2013
Completion
Jul 31, 2013
Last update posted
Oct 31, 2021

2005 – 2013

United States locations

U.S. sites
36
U.S. states
25
U.S. cities
32
Facility City State ZIP Site status
Yale University School of Medicine New Haven Connecticut 06520
University of Florida College of Medicine (Shands) Gainesville Florida 32610
University of Miami Miami Florida 33136
H. Lee Moffitt Cancer Center Tampa Florida 33624
Emory University Atlanta Georgia 30322
St. Lukes Mountain States Tumor Institute Boise Idaho 83712
Loyola University Medical Center Maywood Illinois 60153
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Maryland Medical Systems/Greenbaum Cancer Center Baltimore Maryland 21228
Johns Hopkins/SKCCC Baltimore Maryland 21231
Tufts-New England Medical Center Boston Massachusetts 02111
University of Michigan Medical Center Ann Arbor Michigan 48109
University of Minnesota Minneapolis Minnesota 55455
Washington University/Barnes Jewish Hospital St Louis Missouri 63110
University of Nebraska Omaha Nebraska 68198
Hackensack University Medical Center Hackensack New Jersey 07601
Memorial Sloan-Kettering Cancer Center New York New York 10021
Weill Cornell Medical College, The New York Presbyterian Hospital New York New York 10065
University of Rochester Medical Center Rochester New York 14642
University of North Carolina Hospital at Chapel Hill Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27705
University Hospitals of Cleveland/Case Western Cleveland Ohio 44106
Providence Portland Medical Center Portland Oregon 97213
Columbia River Oncology Program Portland Oregon 97225
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104
Medical University of South Carolina Charleston South Carolina 29425
Cancer Centers of the Carolinas Greenville South Carolina 29615
Vanderbilt University Medical Center Nashville Tennessee 37232
Baylor University Medical Center Dallas Texas 75246
Texas Transplant Institute San Antonio Texas 78229
University of Utah Medical School, BMT Salt Lake City Utah 84132
Intermountain BMT Program Salt Lake City Utah 84143
Virginia Commonwealth University/MCV Hospital Richmond Virginia 23298
Fred Hutchinson Cancer Research Center Seattle Washington 98109
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792
Medical College of Wisconsin Milwaukee Wisconsin 53211

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00329030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00329030 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →